Sybrava (Neratinib) for HER2+ Breast Cancer in India — What Hospitals Need to Know

Among the medicines on A.K. Pharma’s product range that generate significant Google search traffic but relatively few clicks, Sybrava stands out. Over 2,000 impressions per month at position 5 — meaning it appears on the first page of Google for thousands of searches — but a click-through rate of under 1%. That gap between visibility […]